Your browser doesn't support javascript.
COVLIAS 2.0-cXAI: Cloud-Based Explainable Deep Learning System for COVID-19 Lesion Localization in Computed Tomography Scans.
Suri, Jasjit S; Agarwal, Sushant; Chabert, Gian Luca; Carriero, Alessandro; Paschè, Alessio; Danna, Pietro S C; Saba, Luca; Mehmedovic, Armin; Faa, Gavino; Singh, Inder M; Turk, Monika; Chadha, Paramjit S; Johri, Amer M; Khanna, Narendra N; Mavrogeni, Sophie; Laird, John R; Pareek, Gyan; Miner, Martin; Sobel, David W; Balestrieri, Antonella; Sfikakis, Petros P; Tsoulfas, George; Protogerou, Athanasios D; Misra, Durga Prasanna; Agarwal, Vikas; Kitas, George D; Teji, Jagjit S; Al-Maini, Mustafa; Dhanjil, Surinder K; Nicolaides, Andrew; Sharma, Aditya; Rathore, Vijay; Fatemi, Mostafa; Alizad, Azra; Krishnan, Pudukode R; Nagy, Ferenc; Ruzsa, Zoltan; Fouda, Mostafa M; Naidu, Subbaram; Viskovic, Klaudija; Kalra, Mannudeep K.
  • Suri JS; Stroke Diagnostic and Monitoring Division, AtheroPoint™, Roseville, CA 95661, USA.
  • Agarwal S; Advanced Knowledge Engineering Centre, GBTI, Roseville, CA 95661, USA.
  • Chabert GL; Advanced Knowledge Engineering Centre, GBTI, Roseville, CA 95661, USA.
  • Carriero A; Department of Computer Science Engineering, PSIT, Kanpur 209305, India.
  • Paschè A; Department of Radiology, Azienda Ospedaliero Universitaria (A.O.U.), 09123 Cagliari, Italy.
  • Danna PSC; Department of Radiology, "Maggiore della Carità" Hospital, University of Piemonte Orientale (UPO), Via Solaroli 17, 28100 Novara, Italy.
  • Saba L; Department of Radiology, Azienda Ospedaliero Universitaria (A.O.U.), 09123 Cagliari, Italy.
  • Mehmedovic A; Department of Radiology, Azienda Ospedaliero Universitaria (A.O.U.), 09123 Cagliari, Italy.
  • Faa G; Department of Radiology, Azienda Ospedaliero Universitaria (A.O.U.), 09123 Cagliari, Italy.
  • Singh IM; Department of Radiology, University Hospital for Infectious Diseases, 10000 Zagreb, Croatia.
  • Turk M; Department of Pathology, Azienda Ospedaliero Universitaria (A.O.U.), 09124 Cagliari, Italy.
  • Chadha PS; Stroke Diagnostic and Monitoring Division, AtheroPoint™, Roseville, CA 95661, USA.
  • Johri AM; The Hanse-Wissenschaftskolleg Institute for Advanced Study, 27753 Delmenhorst, Germany.
  • Khanna NN; Stroke Diagnostic and Monitoring Division, AtheroPoint™, Roseville, CA 95661, USA.
  • Mavrogeni S; Department of Medicine, Division of Cardiology, Queen's University, Kingston, ON K7L 3N6, Canada.
  • Laird JR; Department of Cardiology, Indraprastha APOLLO Hospitals, New Delhi 110076, India.
  • Pareek G; Cardiology Clinic, Onassis Cardiac Surgery Center, 17674 Athens, Greece.
  • Miner M; Heart and Vascular Institute, Adventist Health St. Helena, St. Helena, CA 94574, USA.
  • Sobel DW; Minimally Invasive Urology Institute, Brown University, Providence, RI 02912, USA.
  • Balestrieri A; Men's Health Center, Miriam Hospital, Providence, RI 02912, USA.
  • Sfikakis PP; Minimally Invasive Urology Institute, Brown University, Providence, RI 02912, USA.
  • Tsoulfas G; Department of Radiology, Azienda Ospedaliero Universitaria (A.O.U.), 09123 Cagliari, Italy.
  • Protogerou AD; Rheumatology Unit, National Kapodistrian University of Athens, 17674 Athens, Greece.
  • Misra DP; Department of Surgery, Aristoteleion University of Thessaloniki, 54124 Thessaloniki, Greece.
  • Agarwal V; Cardiovascular Prevention and Research Unit, Department of Pathophysiology, National & Kapodistrian University of Athens, 15772 Athens, Greece.
  • Kitas GD; Department of Immunology, SGPIMS, Lucknow 226014, India.
  • Teji JS; Department of Immunology, SGPIMS, Lucknow 226014, India.
  • Al-Maini M; Academic Affairs, Dudley Group NHS Foundation Trust, Dudley DY1 2HQ, UK.
  • Dhanjil SK; Arthritis Research UK Epidemiology Unit, Manchester University, Manchester M13 9PL, UK.
  • Nicolaides A; Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL 60611, USA.
  • Sharma A; Allergy, Clinical Immunology and Rheumatology Institute, Toronto, ON M5G 1N8, Canada.
  • Rathore V; AtheroPoint LLC., Roseville, CA 95661, USA.
  • Fatemi M; Vascular Screening and Diagnostic Centre, University of Nicosia Medical School, Engomi 2408, Cyprus.
  • Alizad A; Division of Cardiovascular Medicine, University of Virginia, Charlottesville, VA 22902, USA.
  • Krishnan PR; AtheroPoint LLC., Roseville, CA 95661, USA.
  • Nagy F; Department of Physiology & Biomedical Engineering, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA.
  • Ruzsa Z; Department of Radiology, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA.
  • Fouda MM; Neurology Department, Fortis Hospital, Bengaluru 560076, India.
  • Naidu S; Internal Medicine Department, University of Szeged, 6725 Szeged, Hungary.
  • Viskovic K; Invasive Cardiology Division, University of Szeged, 1122 Budapest, Hungary.
  • Kalra MK; Department of ECE, Idaho State University, Pocatello, ID 83209, USA.
Diagnostics (Basel) ; 12(6)2022 Jun 16.
Article in English | MEDLINE | ID: covidwho-2199863
ABSTRACT

BACKGROUND:

The previous COVID-19 lung diagnosis system lacks both scientific validation and the role of explainable artificial intelligence (AI) for understanding lesion localization. This study presents a cloud-based explainable AI, the "COVLIAS 2.0-cXAI" system using four kinds of class activation maps (CAM) models.

METHODOLOGY:

Our cohort consisted of ~6000 CT slices from two sources (Croatia, 80 COVID-19 patients and Italy, 15 control patients). COVLIAS 2.0-cXAI design consisted of three stages (i) automated lung segmentation using hybrid deep learning ResNet-UNet model by automatic adjustment of Hounsfield units, hyperparameter optimization, and parallel and distributed training, (ii) classification using three kinds of DenseNet (DN) models (DN-121, DN-169, DN-201), and (iii) validation using four kinds of CAM visualization techniques gradient-weighted class activation mapping (Grad-CAM), Grad-CAM++, score-weighted CAM (Score-CAM), and FasterScore-CAM. The COVLIAS 2.0-cXAI was validated by three trained senior radiologists for its stability and reliability. The Friedman test was also performed on the scores of the three radiologists.

RESULTS:

The ResNet-UNet segmentation model resulted in dice similarity of 0.96, Jaccard index of 0.93, a correlation coefficient of 0.99, with a figure-of-merit of 95.99%, while the classifier accuracies for the three DN nets (DN-121, DN-169, and DN-201) were 98%, 98%, and 99% with a loss of ~0.003, ~0.0025, and ~0.002 using 50 epochs, respectively. The mean AUC for all three DN models was 0.99 (p < 0.0001). The COVLIAS 2.0-cXAI showed 80% scans for mean alignment index (MAI) between heatmaps and gold standard, a score of four out of five, establishing the system for clinical settings.

CONCLUSIONS:

The COVLIAS 2.0-cXAI successfully showed a cloud-based explainable AI system for lesion localization in lung CT scans.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Language: English Year: 2022 Document Type: Article Affiliation country: Diagnostics12061482

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Language: English Year: 2022 Document Type: Article Affiliation country: Diagnostics12061482